Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Correction $7.2M cap!
It will. $7.2K cap now with a future revenue run rate of at least $25M. Removal of CEVM can’t happen fast enough.
Thanks for the update. Nice to see it up and running.
I agree with you. They probably forgot to pay the bill. They are going through growth pains no doubt. I just want the CVEM removed. Been told he is waiting for that before other business related PR’s.
The CEO is on it and is getting it rectified. This has nothing to do with the OTC or the CVEM. I have no worries about this.
My sources tell me OTC asked for the 10K for year ending 2/29/20 to be filed, which they have completed and submitted yesterday. Just seems to me market makers have to know something as they have methodically worked the price up to the .05 range on low volume. Actually glad price is here now as removal of CVEM should give it a further bump until they report FY Q1 ending 5/31. The waiting game is frustrating for sure. Been too long to put time frame on it but I am long this one. The OTC attorney they are using and is helping the company navigate this has been very impressed with Dave and what they are doing with the business. My two cents.
Are you using Sirc for the install? Solar or normal roof?
No not due to $ level. They went to zero commission trading with no minimum balance a while back when a number of brokerage houses went this direction. It’s really nice for the reason you mentioned to phase into a position with multiple trades. There are several out there. You check them out.
Sitting at 1.6M shares right now. Can trade freely on Schwab now even with CVEM, w unlimited free trades.
Going current will be big. Heard they were working on their annual numbers year ending 2/29 and that should be complete this week.
Let’s knock out .04
That was wild. I was following it on the one minute chart at the time and it stunned me. I raced in to buy shares, got in mostly at 1.31. Some buying for some in 1.20 area was a gift.
I wondered the same thing. Made me wonder if they delayed earnings to get contracts signed to offset concerns on revenue in this past quarter, to combat not so good news with great news. We’ll see. Good news though is they are in a market that will surely see huge demand (thermal temp/AI) and I can’t ignore their 4-5% stake in Sharecare, which in itself is worth more than the current market cap.
Re entered late today at 1.31. Great entry point imo. MM’s may take it lower and I’ll be buying more if they do. Accumulation time.
Exactly just need volume. Hopefully Dave is planting seeds now too for uplist. After going through this CVEM process they should be well positioned and versed in security mgt to get that process rolling. Hopefully to QB.
I understand and would much prefer your valuation. I am being conservative on the valuation. Really want to see revenues for Q1 to see how they are integrating the acquisitions.
Depends on multiple of sales. Market cap is $3.4M w 138M shares. CEO is projecting $25M annual run rate. Current cap puts it at .13x sales. Assume stock price at 1/2 annual sales puts it at .10. I think .10-.20 is reasonable valuation. All depends on what multiple you out on it. Q1 ending 5/31 will tell the tale as far as how their revenues are running.
Heard from the OTC lawyer today. He said SIRC is very close to having CVEM removed. They are down to a few requests by OTC. The company is very close. I don’t know what those are. He is hopeful they get it removed this week but could slip into next week, and twice reiterated they are close. There are no lingering compliance issues. Been drawn out but it is what it is. I think people are dipping their toes here in the $.03 area in anticipation it is close. In the meantime, I heard they have a backlog of business for up to 6 months so demand is high. And they filled their CFO position. Patience is key here.
If it was dead, price would not have crept up to .03. People waiting to to get in once CVEM comes off. Glad they got the CFO job filled.
They pulled their shelf offering of 125 M shares; means they do not need to do an offering to raise cash at this point.
67K share purchase at .03. Low volume overall w 320k shares but the tide is changing here it seems. Let’s get them skull and bones removed Dave.
Great DD here done on CTYX. CEO ready to take this to the next level.
As data points change the closer we are to getting CVEM removed imo. I plan to call the company’s OTC counsel for an update. They have to be close. All this likely the result of a small company going through massive growth, now with the need for more sophisticated systems in place to help manage their business and data. They’ll be fine. Strong business fundamentals and operational leadership in place to take company to next level.
MARK moving.
Talked to company's OTC legal counsel. The CVEM will be lifted. They are going back and forth with the OTC. The level of CVEM is lowest level so not real significant issues; they are minor. You just never know when the OTC will say enough, but it is coming. Also said there is not a 30 day wait once last document is submitted. He has done a lot of CVEM removals and knows the process. So, the CVEM will be removed once hoops jumped through and OTC boxes checked. Just tough to say when, could be Friday could be two weeks. It is just hard to predict. BTFD! Once the CVEM is lifted then will look to uplist in the next couple months. On a side note, he said he is impressed with CEO as he is doing what he said he was going to do, much different than other clients he services on OTC. Best is yet to come. Impressed with partnership between Dave and Brian. Good days ahead. $25-30M annual revenue run rate with $3M cap.
We have movement. Must be close to removal of CVEM.
I heard the same thing. Let’s see if it actually happens.
I believe the 30 days was for when it first went on caveat designation a few months ago. I’ve heard the annual report for period end 2/29 will be out Wednesday at which time they would be current on reporting. This should get caveat removed. If not CEO needs to explain situation.
Annual run rate is forecasted to be $25M +, not $30M per Q. This came from the CEO, who stated in a PR they are on target for a $6M Q1 2021 fiscal which started 3/1/20. Q4 2020 fiscal which ended 2/29/20 hopefully comes in at around $5M.
Hopefully this lays some tracks to uplist from the pinks. But regardless, this is big. They had a lot to update, all the while integrating the new companies.
If you go to the full form S4 you will are all four of the CVR information. The poster cut and pasted only the info for Roche. They were all allocated the same number of shares when they signed the CVR contracts.
If you did some research you would find that that that are several related securities to LGND; LGNYZ and DZ are among them. You shouldn’t spew “common sense” posts without knowing what you are talking about.
Captisol not copacetic.
LGNDZ correction
LGNZD just posted theirs to the breakout boards FYI
Private company tested entire town of Telluride with antibody test. Bill Ackman just invested in the subsidiary making the test. The anti body testing is about to go big.
https://abcnews.go.com/Health/antibody-testing-colorado-town-provide-forward/story?id=69856623
From publication in an Orange County CA publication yesterday.
Don’t be misled by article title. Good for AYTU mentioned in article. Just a matter of time til PR hits w update.
https://www.google.com/amp/s/www.ocregister.com/2020/03/27/warning-quick-coronavirus-blood-test-could-spell-trouble-experts-say-2/amp/
Excerpts from article:
“No FDA objections”
“The serology tests are not illegal, and the FDA said it “does not intend to object” to their development and distribution by commercial manufacturers, so long as the FDA is notified and patients understand that the test isn’t FDA approved.
That means those like Dao must include a long list of disclaimers in offering the test — including that negative results don’t necessarily rule out coronavirus infection, and that follow-up testing with the molecular diagnostic should be considered to rule out infection for those who’ve had contact with the virus.
Dao’s clinic has included the FDA disclaimers on its Facebook page listing the serology test services.
Many feel that, since molecular testing is in such short supply, the blood tests are worth a try.”
“Last week, at the request of Colorado Gov. Jared Polis, Denver-based AYTU BioScience won emergency-use approval from the FDA to import 100,000 serology test kits from China.”
There has to be evidence of their forecasts and products other than their PR campaign and pictures on a website. Need inputs that involve something from outside the company, i.e. agreements, contracts, media/news about company. Does anyone have any form evidence their plan has any legs?
I do not believe the number of reported cases in China is that low. Hope they deliver on the kits.
China is lying.